Passing the Kool-Aid Point: mRNA Expression-Based Risk Classifiers in Localized Prostate Cancer Treatment Decision Making
Int J Radiat Oncol Biol Phys
.
2023 Jul 1;116(3):530-532.
doi: 10.1016/j.ijrobp.2022.12.002.
Authors
Neil B Desai
1
,
Alan Dal Pra
2
,
Melvin L K Chua
3
,
Alejandro Berlin
4
Affiliations
1
Department of Radiation Oncology, University of Texas Southwestern, Dallas, Texas. Electronic address: Neil.Desai@utsouthwestern.edu.
2
Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, Florida.
3
Department of Radiation Oncology, National Cancer Centre Singapore & Duke-NUS Graduate Medical School, Singapore, Singapore.
4
Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
PMID:
37270247
DOI:
10.1016/j.ijrobp.2022.12.002
No abstract available
Publication types
Editorial
Comment
MeSH terms
Decision Making*
Humans
Male
Patient Participation
Prostatic Neoplasms* / genetics
Prostatic Neoplasms* / radiotherapy
RNA, Messenger
Substances
RNA, Messenger